155 related articles for article (PubMed ID: 9867138)
1. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
[TBL] [Abstract][Full Text] [Related]
2. High-energy (511-keV) imaging with the scintillation camera.
Patton JA; Sandler MP; Ohana I; Weinfeld Z
Radiographics; 1996 Sep; 16(5):1183-94. PubMed ID: 8888397
[TBL] [Abstract][Full Text] [Related]
3. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
Schraml FV; Driver DR; Randolph T; Silverman ED
J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
[TBL] [Abstract][Full Text] [Related]
4. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Martin WH; Jones RC; Delbeke D; Sandler MP
Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
6. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
Bax JJ; Wijns W
J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
[No Abstract] [Full Text] [Related]
8. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
9. [Progress in nuclear cardiology: new imaging beyond perfusion and function].
Tamaki N
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):656-62. PubMed ID: 10565167
[TBL] [Abstract][Full Text] [Related]
10. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
12. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
[TBL] [Abstract][Full Text] [Related]
13. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Delbeke D; Videlefsky S; Patton JA; Campbell MG; Martin WH; Ohana I; Sandler MP
J Nucl Med; 1995 Nov; 36(11):2110-9. PubMed ID: 7472607
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of dual-isotope coincidence/single-photon imaging of the myocardium.
Di Bella EV; Kadrmas DJ; Christian PE
J Nucl Med; 2001 Jun; 42(6):944-50. PubMed ID: 11390561
[TBL] [Abstract][Full Text] [Related]
15. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
Fitzgerald J; Parker JA; Danias PG
J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
[TBL] [Abstract][Full Text] [Related]
16. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
[TBL] [Abstract][Full Text] [Related]
17. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
19. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
20. FDG-SPECT: correlation with FDG-PET.
Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
